Harvard Bioscience Inc

HBIONASDAQ • USD
9.27 USD
↗ 0.36 (4.00%)🟢LIVE (AS OF 02:25 PM EST)
🟢Market: OPEN

Harvard Bioscience Inc (HBIO) is currently trading at $9.27. HBIO shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On valuation, HBIO trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Nov 16, 2026.

Open?$9.00
High?$9.52
Low?$7.85
Prev. Close?$8.91
Volume?14.2K
Avg. Volume?24.4K
VWAP?$9.16
Rel. Volume?0.58x
Bid / Ask
Bid?$7.74 × 100
Ask?$10.66 × 100
Spread?$2.92
Midpoint?$9.20
Valuation & Ratios
Market Cap?40.7M
Shares Out?4.6M
Float?3.4M
Float %?74.3%
P/E Ratio?N/A
P/B Ratio?7.98
EPS?-$2.58
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.
Employees
339
Market Cap
42.9M
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Listed
2000-12-07
Address
84 OCTOBER HILL RD
HOLLISTON, MA 01746
Phone: (508) 893-8999
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
35
Short Sent.?
48
Piotroski F-Score?2/9Weak
Altman Z-Score?-2.38Distress
Confidence?59%Low
Full Fundamental Analysis →
Short InterestModerate
Short % of Float?1.96%Low
Short Interest?66.5K
Days to Cover?3.5
Free Float3.4M
Avg Daily Volume19.0K
Settlement Date2026-10-30
Financial Health
Current Ratio?1.76Adequate
Quick Ratio?0.86Weak
Cash Ratio?0.19Low
Debt/Equity?7.28High
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
75/100
P/E?
N/A▾
P/B?
Peers
100
S&P
24
7.98FAIR▾
P/S?
Peers
100
S&P
97
0.46CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
21
21.3HIGH▾
EV/Sales?
Peers
100
S&P
94
0.82CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-231.2%WEAK▾
ROA?
S&P
3
-15.7%WEAK▾
Cash Flow & Enterprise
FCF?$-3171000
Enterprise Value?$73.0M
Fundamentals ratios updated end of day